Development and validation of a chiral bioanalytical method for pharmacokinetic evaluation of paroxetine enantiomers: Insights into enantiomeric interconversion
Abstract
Translate Article 
Take Notes
Development and validation of a chiral bioanalytical method for pharmacokinetic evaluation of paroxetine enantiomers: Insights into enantiomeric interconversion
ReferencesShowing 10 of 10 papersGreen chromatographic methods for simultaneous determination of quetiapine and the co-administrated paroxetine in rat plasma with application to pharmacokinetic study Pharmacologically active compounds in the environment and their chirality Method development and validation for the HPLC assay (potency and related substances) for 20 mg paroxetine tablets New validated HPLC methodology for the determination of (−)-trans-paroxetine and its enantiomer in pharmaceutical formulations with use of ovomucoid chiral stationary phase Determination of Paroxetine in Pharmaceutical Preparations Using HPLC with Electrochemical Detection Advances and applications of chiral resolution in pharmaceutical field Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods Recent trends in chiral supercritical fluid chromatography Chirality in Modern Antidepressants: A Comprehensive Review of Stereochemical Impacts on Pharmacology and Therapeutics Current trends in the development of new antidepressants.
6
- 10.1016/j.microc.2019.104317
- Oct 14, 2019
- Microchemical Journal
403
- 10.1039/c000408c
- Jan 1, 2010
- Chemical Society Reviews
29
- 10.1016/s0731-7085(98)00309-4
- Feb 22, 1999
- Journal of Pharmaceutical and Biomedical Analysis
7
- 10.1007/s00216-013-7565-y
- Jan 1, 2014
- Analytical and Bioanalytical Chemistry
22
- 10.2174/1874065001307010001
- Jan 24, 2013
- The Open Analytical Chemistry Journal
76
- 10.1002/chir.23453
- Jun 8, 2022
- Chirality
100
- 10.3390/molecules26113113
- May 23, 2021
- Molecules
146
- 10.1016/j.trac.2019.115648
- Sep 5, 2019
- TrAC Trends in Analytical Chemistry
2
- 10.3390/ddc3040037
- Sep 27, 2024
- Drugs and Drug Candidates
140
- 10.2174/0929867013373796
- Feb 1, 2001
- Current Medicinal Chemistry
More from: Current Pharmaceutical AnalysisIdentification and characterization of the Fd+ 16 Da fragment impurity in therapeutic CD47 monoclonal antibodies expressed in CHO-K1 cell lines Analytical Advances in the Quantitative and Qualitative Determination of Clonidine and Methyldopa: A Review An automated sample pretreatment system for liquid–liquid extraction and its application in the analysis of four steroid hormones in human plasma Unveiling cloperastine fendizoate degradation using MS/MS: A novel HPLC method for simultaneous analysis with parabens and degradant characterization Impact of sodium carbonate processing on the chemical profile and antimicrobial properties of saussurea lappa root extracts Two-Dimensional HPLC Method for Determining Linezolid Concentrations in Plasma and Its Clinical Application in Therapeutic Drug Monitoring An effective high-performance liquid chromatography method for fingerprint and multi-component quantification of Oxalis corniculata Development and validation of a chiral bioanalytical method for pharmacokinetic evaluation of paroxetine enantiomers: Insights into enantiomeric interconversion Colorimetric detection and quantification of glutathione in human serum using the peroxidase-like activity of MOF-808FA frameworks Integrated analysis of liquid chromatography-mass spectrometry and network pharmacology identified active compounds of Paeoniae Radix Alba for myasthenia gravis treatment
- Research Article
- 10.1016/j.cpan.2025.10.002
- Nov 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.10.001
- Oct 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.09.004
- Oct 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.08.005
- Oct 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.09.002
- Oct 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.09.008
- Sep 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.09.005
- Sep 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.08.006
- Sep 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.08.002
- Sep 1, 2025
- Current Pharmaceutical Analysis
- Research Article
- 10.1016/j.cpan.2025.08.008
- Sep 1, 2025
- Current Pharmaceutical Analysis
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.